California Democratic Senator Adam Schiff has initiated a congressional inquiry into the Justice Department’s decision to close a criminal investigation into Cronobacter contamination at an Abbott Laboratories plant that produced baby formula. In a letter to acting Attorney General Todd Blanche, Schiff questioned why DOJ officials did not heed prosecutors’ recommendations to pursue felony charges against Abbott and its executives. The inquiry follows a 2022 recall of Abbott’s powdered formula brands linked to infant illnesses, with reports indicating hospitalization of five infants, two of whom died. Abbott has maintained that its products tested negative for the bacteria, although one strain was found on a breast pump part related to one case. Senior DOJ officials opted for a civil resolution instead of criminal prosecution, citing it as a more effective means of ensuring accountability and public protection.
Why It Matters
This investigation highlights ongoing concerns about corporate accountability in public health matters, particularly regarding food safety. Abbott Laboratories faced significant scrutiny after its products were linked to severe health risks for infants, raising questions about regulatory oversight in the food manufacturing sector. The closure of the criminal investigation raises alarms about the Justice Department’s commitment to pursuing corporate malfeasance, especially when public health is at stake. Historical patterns show that corporations often navigate legal repercussions through civil settlements rather than facing criminal charges, which may undermine deterrence against future violations.
Want More Context? 🔎
